Awards
- A Randomized, Double-blind, Single-Centre, Placebo-controlled Study of Antigen-specific Sublingual immunotherapy plus Dupilumab for Induction of Tolerance in Adults with Moderate-Severe Seasonal Allergic Rhinitis. (GRADUATE $6,470,262, Immune Tolerance Network, NIAID, NIH USA. Principal investigator. Feb 2020 - May 2025, 2020
External Positions
- International External Adviser, Inner City Asthma Consortium, NIAID USA, 2014 - 2021
- Member and Head Allergy Assessment Committee, Immune Tolerance Network National Executive Committee (NEC), NIAID, 2013 - 2021
- Member, Immune Tolerance Network National Steering Committee, NIAID USA, 2005 - 2025